Pamidronate in the treatment of childhood SAPHO syndrome

Rheumatology
C KerrisonM W Beresford

Abstract

SAPHO syndrome is increasingly recognized within the paediatric population. Conventional therapeutic approaches have often not been effective. Pamidronate is a second-generation bisphosphonate that affects bone turnover and demonstrates anti-inflammatory properties. In small case series it has given symptomatic relief to adults with this condition. To report the clinical experience with pamidronate in childhood SAPHO syndrome. A retrospective observational study of all children with SAPHO syndrome treated with pamidronate between 1996 and 2003 at a tertiary rheumatology centre. The standard dosing regime for pamidronate was 1 mg/kg to a maximum of 30 mg, administered daily for three consecutive days, repeated 3-monthly as required. Response to treatment was determined by clinical observation, patient subjective response and reduction in other treatments Seven girls were treated, with a median (range) age at diagnosis of 11 yr (9-15 yr). All patients demonstrated a beneficial clinical response, with relief of pain, increased activity and improved well-being. Subsequent courses of pamidronate were used in all patients. Other medications including corticosteroids and methotrexate could subsequently be stopped. Transient symptoms w...Continue Reading

Citations

Nov 11, 2008·Rheumatology International·Jiro IchikawaYoshiki Hamada
Aug 20, 2009·Clinical Rheumatology·Gleb SlobodinMajed Odeh
May 23, 2013·Journal of Clinical Immunology·Patrícia Costa-Reis, Kathleen E Sullivan
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Peter K Wung, John H Stone
Jul 27, 2011·Current Opinion in Rheumatology·Marinka Twilt, Ronald M Laxer
Mar 27, 2010·European Journal of Pediatrics·Toni HospachGuenther E Dannecker
Mar 24, 2009·Der Orthopäde·A JanssonA von Liebe
Feb 25, 2014·Joint, Bone, Spine : Revue Du Rhumatisme·Emilie DelattreDaniel Wendling
Sep 24, 2009·Current Rheumatology Reports·Marina Magrey, Muhammad A Khan
Feb 24, 2012·Current Rheumatology Reports·Polly J Ferguson, Monica Sandu
Sep 23, 2006·Expert Opinion on Investigational Drugs·Ignazio OlivieriCarlo Palazzi
Nov 5, 2013·Rheumatic Diseases Clinics of North America·Sara M Stern, Polly J Ferguson
Jan 15, 2015·Journal of Children's Orthopaedics·Iva Rukavina
Apr 20, 2013·Rheumatic Diseases Clinics of North America·Sueli Carneiro, Percival D Sampaio-Barros
Nov 22, 2011·Best Practice & Research. Clinical Rheumatology·G Assmann, P Simon
Mar 29, 2011·Joint, Bone, Spine : Revue Du Rhumatisme·Julien WipffChantal Job-Deslandre
Aug 3, 2010·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Wolfgang ZemannHans Kaercher
Mar 1, 2007·Reumatología clinica·Miriam Centeno JiménezPaz Collado
Jan 11, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Michael W BeresfordKathleen E Sullivan
Mar 10, 2007·Joint, Bone, Spine : Revue Du Rhumatisme·Gilles Hayem
Feb 13, 2008·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander JustPeter Frosch
Oct 17, 2013·The Journal of Dermatology·Toshiyuki Yamamoto
Dec 30, 2014·Arthritis & Rheumatology·J WipffC Job-Deslandre
Oct 3, 2006·Joint, Bone, Spine : Revue Du Rhumatisme·Pierre-Louis DocquierJean-Jacques Rombouts
Mar 19, 2008·The Journal of Pediatrics·Peter J SimmMargaret R Zacharin
Nov 17, 2012·Seminars in Arthritis and Rheumatism·Minhchau Thi NguyenM Eric Gershwin
Oct 29, 2015·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·Estefanía Barral MenaJaime de Inocencio Arocena
Aug 19, 2014·Mediators of Inflammation·Donato RiganteLuca Cantarini
May 15, 2012·Orthopaedics & Traumatology, Surgery & Research : OTSR·M T KennedyP Connolly
Dec 21, 2016·Reumatología clinica·Manuel Vargas Pérez, Belén Sevilla Pérez
Jul 12, 2017·Pediatric Rheumatology Online Journal·Yurika AtaTomoyuki Saito
Mar 6, 2018·Journal of Paediatrics and Child Health·Peter J SimmUNKNOWN APEG Bone Mineral Working Group
Nov 8, 2017·Arthritis Care & Research·Yongdong ZhaoUNKNOWN Chronic Nonbacterial Osteomyelitis/Chronic Recurrent Multifocal Osteomyelitis Study Group and the Childhood Arthritis and Rh
May 15, 2007·Clinical Orthopaedics and Related Research·Hatem I El-Shanti, Polly J Ferguson
Jan 19, 2019·BMC Musculoskeletal Disorders·Yalong LiTiancheng Lu
Oct 17, 2019·The Journal of Rheumatology·Changlong GuoXu Ma
Jan 9, 2019·BMJ Case Reports·Chin-Fang SuChang-Youh Tsai
Dec 31, 2017·Pediatric Rheumatology Online Journal·Andrea TaddioMarco Gattorno
Mar 4, 2021·Scandinavian Journal of Rheumatology·A S SælenS Løes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.